This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA test...
As winter weather continues to move through parts of the US, we would like to remind you it may be n...
We are informing you that the FDA has announced their withdrawal of Guidance for ZIKV Testing. In th...
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
On January 25, 2021, CTS implements the Ortho VIP viral marker testing platform. Conversion from the...